Today was biotech sell off. Take a look at JUNO. No news is good news. Just hope there is no bad news. Nothing else to do than sit tight.
This is a great hypothesis. I agree. The money would flow in and give a rise to the whole field of stocks in this area. Nice move on NWBO today. It's definitely a positive indicator to take out 9 even should it fall later in the day. I see the MO-MO up!
Bio, as a pharmacist, I have yet to dispense Belviq. Can you #$%$ believe it? No Contrave either. I did dispense a Myrbetriq a few times though some folks balk at the high copay and it becomes a return-to-stock and contact MD for a less expensive alternative. The Eisai rep came by this pharmacy to hand out consumer coupons for $75 per month if no insurance. I did not get a chance to talk to this fine, buxom lady because I was helping some old bag at the register trying to find her script and the whole time going absolutely nuts because I wanted to ask her a number of questions and also because she was a fine, buxom young lady. :)
I putting my money on these days immunotherapy plays like CLDX and JUNO. Interesting chart on ARNA, but I agree they will have to come up with something new to excite the stock.
I'd have to say the last two days have been great for NWBO. Good volume and especially on two down days in market indices. I'll consider building a position again. Got other positions to sit on and will watch what happens with Greece, interest rates, etc., but if the pps takes out the old high, I say look out!
I would hold this. Only a fool would think this is a pump and dump. Not with markets overall so negative. There is some killer good news coming very soon. Maybe today, tomorrow, but very soon. This kind of volume does not happen for no reason-usually. I bought back the call options I sold yesterday as I felt the market was heading south. Bought them back today. As a pharmacist, I think their drug is going to be a big seller. No effective treatments for PDP and I think their trials for ADP is just as compelling to own it. GL!
Could be they are comparing it to Provenge from Dendreon and the slow sales. Good article on Forbes with a money manager stating his reasons for owning NWBO. Supposed to be some info from trials this ASCO in May. Lets hope for the best.
i got turned onto EPL by a Mexican guy I know a few years ago, He liked the food and told me about them. I have bought their burritos primarily and have bought them for people who have worked for me and everyone liked them. I think they are much better than Taco Bell. I agree the menu is a bit confusing. I think it could be better organized. I do think their salads are a great idea for those looking to watch calories. I had a new one open up close to me recently. I think they can really capitalize on the after work crowd who want more than just a burrito, but a healthy meal with chicken or fish, more veggies and potatoes or rice. I think they can be what Boston Chicken used to be many years ago .People want more (I do) than a lousy burger and fries all the time. Create healthy meals with some variety or options for veggies and they will trounce the competition.
Looks good today for sure. Nice move up on better volume. I think the Canadian info gave a little more credence to NWBO. (smile). :)
I own JUNO, CLDX and NWBO. Regarding this cytokine storm, lets clarify and stay in the realm of reality and not pumping and poooping...
CAR T-cell therapy can cause several worrisome side effects, perhaps the most troublesome being cytokine-release syndrome.
The infused T cells release cytokines, which are chemical messengers that help the T cells carry out their duties. With cytokine-release syndrome, there is a rapid and massive release of cytokines into the bloodstream, which can lead to dangerously high fevers and precipitous drops in blood pressure.
Cytokine-release syndrome is a common problem in patients treated with CAR T cells. In the POB and CHOP trials, patients with the most extensive disease prior to receiving the CAR T cells were more likely to experience severe cases of cytokine-release syndrome.
For most patients, trial investigators have reported, the side effects are mild enough that they can be managed with standard supportive therapies, including steroids.
The research team at CHOP noticed that patients experiencing severe reactions all had particularly high levels of IL-6, a cytokine that is secreted by T cells and macrophages in response to inflammation. So they turned to two drugs that are approved to treat inflammatory conditions like juvenile arthritis: etanercept (Enbrel®) and tocilizumab (Actemra®), the latter of which blocks IL-6 activity.
The patients had “excellent responses” to the treatment, Dr. Grupp said. “We believe that [these drugs] will be a major part of toxicity management for these patients.”
The other two teams subsequently used tocilizumab in several patients. Dr. Brentjens agreed that both drugs could become a useful way to help manage cytokine-release syndrome because, unlike steroids, they don’t appear to affect the infused CAR T cells’ activity or proliferation.
The chart speaks louder than you. Sorry. When it hits 8 then takes out 10, then I know "something" bigger is around the corner. Till then, I will read Smith's articles with much fanfare (sincere about this as I like this guy) and hope for the best for all of us.
I believe this drug this drug has helped some folks, but there is A LOT of ambiguity from Powers. Not sure if this is legal mumbo-jumbo to protect NWBO from frivolous law suits or just lack of samples/poor sick folks to show statistical significance. I'm long with 3000 and if it goes to 100, that's great and if it goes to zero I can take the punch. I would not put one penny in here unless you throw the money away and still smoke a cigar and say "Ciao my sweet money" as I am right now.
The ambiguity and cloudiness of these phase studies caused me to drop the amount of shares i hold from 17,000 to 3,000. There is nothing concrete except individual results. I believe in the technology, but where is the solid P
I agree. If we can stay at current support, next resistance is from back in August 2014 of 7.2. I'd really like to seek some strong volume for validity. Nice move Friday.
I think it's a silly idea too. I think these guys are pulling our legs. Anyway, let the science speak for itself and lets hope for a happy ending for all us longs. The shorts, another story.